Skip to main content
63°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Halberd Corporation
< Previous
1
2
Next >
Halberd's PTSD/Alzheimer's R&D Reveals Link to Potential Obesity Cure
October 20, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd and GTX Corp. Sign Scientific Collaboration and Reseller Agreement
October 12, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
GTXO
HALB
Halberd Corporation CEO Letter
October 07, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Death
Intellectual Property
Tickers
HALB
Halberd's VITASHIELDMAX(TM) Immunity Support Product Available on Amazon
October 05, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd and heliosDX of RushNet Enter Scientific Collaboration Agreement
September 22, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
RSHN
Halberd's Treatment Eradicates Primary Building Block of Alzheimer’s Disease
September 13, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Appoints Anthony Mirabelli Vice-President, Mergers & Acquisitions
September 08, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Alzheimer's Disease Treatment Tests Yield Outstanding Results
August 30, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Receives Patent for Treatment of Cockayne Syndrome - May Provide Pathway to Slow Aging
August 25, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Files Provisional Patent Application - Furthering Efforts on Alzheimer's Disease
August 23, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
HALB
Halberd Corp. VITA-SHIELD-MAX(TM) Available - Buy Now!
August 18, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd’s Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN
August 16, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Adds Blood-Borne Disease Treatment Capability With Addition Of Noted Nephrologist
August 11, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Death
Intellectual Property
Tickers
HALB
Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped
August 09, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"
July 28, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
HALB
Halberd Corp. Advances the Elimination of Antigens Present in Alzheimer’s Disease & PTSD/Chronic Traumatic Encephalopathy
July 22, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
HALB
Halberd Corporation CEO Letter
July 06, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
HALB
Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process
June 30, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation's Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage Process
June 21, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens
June 16, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease
June 09, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Death
Intellectual Property
Tickers
HALB
Halberd Corporation Creates Two New and Stronger SARS-CoV-2 Neutralizing Antibodies
June 07, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Animal Testing
Intellectual Property
Regulatory Compliance
Exposures
Animal Testing
COVID-19
Intellectual Property
Tickers
HALB
Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects
June 01, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Successfully Conjugates Metallic Particles and E. Coli Antibody
May 25, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19
May 19, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Reports Successful Conjugation of Metallic Particles & SARS-CoV-2 Proprietary Monoclonal Antibody
May 17, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Begins Testing of Patented Process for Laser Eradication of Disease
May 13, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications
May 10, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease
May 04, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser
April 26, 2021
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Tickers
HALB
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.